ORG Partners LLC: SHLD position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORG Partners LLC on SHLD, newest first. How the timeline and the estimate are built.
ORG Partners LLC held 19,037 SHLD shares at 2025-12-31 per its 13F-HR filed 2026-01-14.
the latest 13F is the newest step
- period ended2025-12-3113F 19,037 sharesChange vs previous 13F -3,527 shares
0.22% of the 13F portfolio, value $1,234,457.
13F-HR 0001979372-26-000001 filed by ORG Partners LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 22,564 sharesChange vs previous 13F +4,999 shares
0.29% of the 13F portfolio, value $1,586,048.
13F-HR 0001979372-25-000008 filed by ORG Partners LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 17,565 sharesChange vs previous 13F +512 shares
0.22% of the 13F portfolio, value $1,034,200.
13F-HR 0001979372-25-000004 filed by ORG Partners LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 17,053 sharesChange vs previous 13F +1,866 shares
0.2% of the 13F portfolio, value $802,339.
13F-HR 0002032602-25-000002 filed by ORG Partners LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 15,187 sharesChange vs previous 13F -480 shares
0.08% of the 13F portfolio, value $568,125.
13F-HR 0001979372-25-000001 filed by ORG Partners LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 15,667 sharesChange vs previous 13F not available
0.09% of the 13F portfolio, value $583,266.
13F-HR 0001979372-24-000004 filed by ORG Partners LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).